Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation.


Journal

BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547

Informations de publication

Date de publication:
08 Feb 2019
Historique:
received: 19 02 2018
accepted: 25 01 2019
entrez: 10 2 2019
pubmed: 10 2 2019
medline: 28 2 2019
Statut: epublish

Résumé

Liver transplantation (LT) is considered the standard treatment for end-stage liver disease, but ideal donors remain in limited supply, resulting in an unavoidable increase in the need to use grafts from marginal donors. The attenuation of ischemia-reperfusion injury (IRI) in such marginal donors is therefore crucial for reducing the possibility of the primary non-function of grafts and graft loss. Some reports have found that molecular-hydrogen showed antioxidant and anti-inflammatory effects in preventing IRI in some non-hepatic transplant models. Therefore, we investigated whether or not molecular-hydrogen could attenuate IRI in LT model rats. We used a hydrogen-rich water bath to dissolve hydrogen into solution and graft tissues and performed isogenic and orthotopic LT in Lewis rats with University of Wisconsin (UW) solution. Blood and tissue samples were collected 6 h after the reperfusion. Hepatic enzymes in serum were measured. Pathological findings including the expressions of cytokines and heme oxygenase (HO)-1 in liver tissues were evaluated. The concentration of hydrogen inside the graft tissues increased depending on the storage time, plateauing after 1 h. Serum liver enzyme levels were significantly lower and the histology score of liver damage markedly attenuated in the group given grafts preserved in hydrogen-rich UW solution than in the control group. The hydrogen-rich UW solution group also showed less oxidative damage and hepatocyte apoptosis than the control group, and the expression of proinflammatory cytokines tended to be lower while the protein levels of HO-1 were significantly increased (n = 3-12 per group, P < 0.05). Storage of liver grafts in hydrogen-rich UW solution resulted in superior functional and morphologic protection against IRI via the up-regulation of HO-1 expression.

Sections du résumé

BACKGROUND BACKGROUND
Liver transplantation (LT) is considered the standard treatment for end-stage liver disease, but ideal donors remain in limited supply, resulting in an unavoidable increase in the need to use grafts from marginal donors. The attenuation of ischemia-reperfusion injury (IRI) in such marginal donors is therefore crucial for reducing the possibility of the primary non-function of grafts and graft loss. Some reports have found that molecular-hydrogen showed antioxidant and anti-inflammatory effects in preventing IRI in some non-hepatic transplant models. Therefore, we investigated whether or not molecular-hydrogen could attenuate IRI in LT model rats.
METHODS METHODS
We used a hydrogen-rich water bath to dissolve hydrogen into solution and graft tissues and performed isogenic and orthotopic LT in Lewis rats with University of Wisconsin (UW) solution. Blood and tissue samples were collected 6 h after the reperfusion. Hepatic enzymes in serum were measured. Pathological findings including the expressions of cytokines and heme oxygenase (HO)-1 in liver tissues were evaluated.
RESULTS RESULTS
The concentration of hydrogen inside the graft tissues increased depending on the storage time, plateauing after 1 h. Serum liver enzyme levels were significantly lower and the histology score of liver damage markedly attenuated in the group given grafts preserved in hydrogen-rich UW solution than in the control group. The hydrogen-rich UW solution group also showed less oxidative damage and hepatocyte apoptosis than the control group, and the expression of proinflammatory cytokines tended to be lower while the protein levels of HO-1 were significantly increased (n = 3-12 per group, P < 0.05).
CONCLUSIONS CONCLUSIONS
Storage of liver grafts in hydrogen-rich UW solution resulted in superior functional and morphologic protection against IRI via the up-regulation of HO-1 expression.

Identifiants

pubmed: 30736744
doi: 10.1186/s12876-019-0939-7
pii: 10.1186/s12876-019-0939-7
pmc: PMC6368804
doi:

Substances chimiques

Insulin 0
Organ Preservation Solutions 0
RNA, Messenger 0
University of Wisconsin-lactobionate solution 0
Allopurinol 63CZ7GJN5I
Hydrogen 7YNJ3PO35Z
Glutathione GAN16C9B8O
Adenosine K72T3FS567
Raffinose N5O3QU595M

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25

Subventions

Organisme : This study was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan
ID : MEXT; Grants-in-Aid 16K10432

Références

Lancet. 2002 Feb 16;359(9306):604-13
pubmed: 11867131
Am J Transplant. 2001 Jul;1(2):121-8
pubmed: 12099359
Exp Mol Pathol. 2003 Apr;74(2):86-93
pubmed: 12710939
Liver Transpl. 2003 Jul;9(7):651-63
pubmed: 12827549
Gastroenterology. 2003 Sep;125(3):917-36
pubmed: 12949736
Lancet. 1992 Dec 5;340(8832):1373-6
pubmed: 1360089
Am J Transplant. 2007 Apr;7(4):1003-9
pubmed: 17286618
Nat Med. 2007 Jun;13(6):688-94
pubmed: 17486089
Cell Transplant. 2008;17(1-2):99-109
pubmed: 18468240
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):487-92
pubmed: 19834032
Hepatology. 1991 Jan;13(1):83-95
pubmed: 1988348
Am J Physiol. 1991 Mar;260(3 Pt 1):G355-62
pubmed: 2003603
Liver Transpl. 2010 Sep;16(9):1016-32
pubmed: 20818739
Am J Transplant. 2011 Aug;11(8):1563-9
pubmed: 21668640
Med Gas Res. 2012 Jan 24;2:1
pubmed: 22273079
World J Gastroenterol. 2012 Apr 21;18(15):1765-72
pubmed: 22553400
Transplantation. 2012 Jul 15;94(1):14-21
pubmed: 22683850
J Heart Lung Transplant. 2013 Feb;32(2):241-50
pubmed: 23273745
Sci Rep. 2014 Jun 30;4:5485
pubmed: 24975958
Transplantation. 2015 Mar;99(3):500-7
pubmed: 25539463
PLoS One. 2015 Apr 28;10(4):e0122214
pubmed: 25919110
Med Gas Res. 2015 Oct 26;5:13
pubmed: 26504515
World J Gastroenterol. 2016 May 14;22(18):4438-45
pubmed: 27182155
Biochem Biophys Res Commun. 2017 Feb 5;483(2):885-891
pubmed: 28077277
J Crit Care. 2017 Oct;41:156-160
pubmed: 28551489
Transplantation. 1979 Jul;28(1):47-50
pubmed: 377595
Transplantation. 1993 Jun;55(6):1265-72
pubmed: 7685932
Am J Respir Cell Mol Biol. 1996 Jul;15(1):9-19
pubmed: 8679227

Auteurs

Keiichi Uto (K)

Department of Transplantation and Pediatric Surgery, Postgraduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.

Seisuke Sakamoto (S)

Organ Transplant Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. sakamoto-si@ncchd.go.jp.

Weitao Que (W)

Division of Transplantation Immunology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Department of Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 800 Dongchuan RD. Minhang District, Shanghai, 201100, China.

Keita Shimata (K)

Department of Transplantation and Pediatric Surgery, Postgraduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.

Shintaro Hashimoto (S)

Department of Transplantation and Pediatric Surgery, Postgraduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.

Masataka Sakisaka (M)

Department of Transplantation and Pediatric Surgery, Postgraduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.

Yasuko Narita (Y)

Department of Transplantation and Pediatric Surgery, Postgraduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.

Daiki Yoshii (D)

Department of Transplantation and Pediatric Surgery, Postgraduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.

Lin Zhong (L)

Department of Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 800 Dongchuan RD. Minhang District, Shanghai, 201100, China.

Yoshihiro Komohara (Y)

Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.

Xiao-Kang Li (XK)

Division of Transplantation Immunology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.

Yukihiro Inomata (Y)

Department of Transplantation and Pediatric Surgery, Postgraduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.

Taizo Hibi (T)

Department of Transplantation and Pediatric Surgery, Postgraduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH